Background {#Sec1}
==========

Pain is a non-specific symptom that can be found in several musculoskeletal disorders such as myofascial pain syndrome, fibromyalgia, tendinitis and arthritis \[[@CR1]\]. Pathogenesis of pain is attributed to initiation of cellular damage and connective tissue damage through a number of mechanisms related to inflammation and oxidative stress. Some of secreted chemotactic molecules and mediators including cytokines can also trigger excessive reactive oxygen species (ROS) formation \[[@CR2], [@CR3]\].

IL-1β, a pro-inflammatory cytokines, plays a critical role during tissue injury and inflammation such as activating p38 mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (JNK), nuclear factor-kappa B (NF-κB), extracellular signal-regulated kinase (ERK) signal transduction, increasing COX-2 activity and proinflammatory cytokines (IL-6, IL-8,TNF-α, IL-1) \[[@CR4]\] and regulating ROS, collagen, proteoglycans synthesis in connective tissue \[[@CR5]\]. While nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin, diclofenac, aspirin and ibuprofen are commonly used as anti-inflammatory and analgesic agents for relieving pain, the prolong use of NSAIDs could cause various side effects, such as gastrointestinal irritation, renal impairment, hepatotoxicity and allergic reaction \[[@CR6]\].

Thai herbal Sahatsatara formula (STF), a polyherbal formula, recognized in the National List of Essential Medicines, is used to relief muscle pain, limb numbness and carminative. The formula is composed of 21 medicinal ingredients: camphor (1, 7, 7 -- trimethylbicyclo (2.2.1) heptan −2- one), *Acorus calamus* L., *Atractylodes lancea* (Thunb.) DC., *Baliospermum solanifolium* (Burm.) Suresh., *Pistacia chinensis* subsp. *integerrima* (J. L. Stewart ex Brandis) Rech. f. Lagasca., *Picrorhiza kurroa* Royle ex Benth., *Plumbago indica* L., *Anethum graveolens* L*.,Cuminium cyminum* L., *Lepidium sativum* L., *Nigella sativa* L.,*Pimpinella anisum* L., *Clausena excavate* Burm.f., *Merremia vitifolia* (Burm.f.) Hallier.f, *Myristica fragrans* Houtt. (fruit and mace), *Piper nigrum* L., *Piper retrofractum* Vahl. *Terminalia chebula* Retz. (fruit and gall) and *Ferula assa-foetida* Regel*.* Previous studies demonstrated that STF showed effective anti-inflammatory activities by inhibiting COX-2 protein level and NO production by LPS-induced murine macrophages (RAW246.7). Moreover, STF and its component extracts also yielded the DPPH radical scavenging activity \[[@CR7]\]. Recent clinical studies suggested that STF could attenuate symptoms from muscle pain \[[@CR8]\] and osteoarthritis \[[@CR9]\]. Although STF is widely used in Thai traditional practice, the evidence-based data regarding its active compounds and pharmacological effects which support the traditional usage are still unclear. This study thus aimed to; 1) identify active substances of STF by chromatography techniques, 2) determine the free radical scavenging properties of STF, its component extracts and its possibly active compounds using cell-free 2, 2-dipheny-1-picrylhydrazyl (DPPH) assay and 3) investigate antioxidant actions and the modulation by STF and its active compounds of the gene expression profile using microarray analysis using IL-1β-treated primary human dermal fibroblasts (NHDFs) culture model.

Methods {#Sec2}
=======

Materials and reagents {#Sec3}
----------------------

The STF composes of 21 components (Table [1](#Tab1){ref-type="table"}). The crude powder of STF and its ingredients was supported by Center of Applied Thai Traditional Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University. The characteristic of individual material was circumspectly authenticated by two experienced applied Thai traditional practitioners. The formula and ingredient powder was processed by the Manufacturing Unit of Herbal Medicines and Products Ayurved Siriraj under Good Manufacturing Practice (GMP) certification. Normal human dermal fibroblasts (NHDFs) and 2% fibroblast basal medium (FBM) were purchased from LONZA (LONZA, USA). The analytical grade ethanol and methanol reagents were purchased from Scharlau (Scharlau, Spain). All chemical reagents were obtained from Sigma-Aldrich (MO, USA).Table 1The percentage yields and IC~30~ values of free radical scavenging activities of STF extracts, its components and active compounds were obtained from DPPH assay and represented as Mean ± SEM. in triplicate experiments. IC~30~ values indicated concentrations of the test compounds required to scavenge DPPH radical by 30%No.Material namePart of usagePercentage of components in formula (W/W)^a^% yields (W/W)^a^DPPH assay IC~30~ value (μg/mL)1L-ascorbic acid\-\--3.32 ± 0.222Piperine\-\--\>1203Gallic acid\-\--8.04 ± 0.944STF formula\--19.7819.62 ± 1.1351,7, 7 -- trimethylbicyclo (2.2.1) heptan −2- one (analytical camphor)crystal1.40-\>1206*Acorus calamus* L.root8.801.73\>1207*Anethum graveolens* L*.*seed1.002.82\>1208*Atractylodes lancea* (Thunb.) DC.root0.506.83\>1209*Baliospermum solanifolium* (Burm.) Sureshroot8.000.7490.86 ± 16.9610*Clausena excavate* Burm.f.stem4.802.3098.47 ± 4.8111*Cuminium cyminum* L.seed0.806.2675.67 ± 11.6312*Ferula assa-foetida Regel*gum1.0027.89\>12013*Lepidium sativum* L.seed1.107.8349.43 ± 5.4214*Merremia vitifolia* (Burm.f.) Hallier.f.stem0.801.4925.17 ± 2.3415*Myristica fragrans* Houtt.fruit1.301.0119.99 ± 1.1716*Myristica fragrans* Houtt.mace1.202.0231.35 ± 3.1317*Nigella sativa* L.seed0.709.21\>12018*Pistacia chinensis subsp. integerrima (J. L. Stewart ex Brandis) Rech. f. Lagasca.*root0.6011.0965.57 ± 8.8119*Picrorhiza kurroa* Royle ex Benth.root0.407.7084.96 ± 1.1820*Pimpinella anisum* L.seed0.905.4078.54 ± 7.4721*Piper nigrum* L.fruit24.000.03\>12022*Piper retrofractum* Vahl.fruit9.606.03\>12023*Plumbago indica* L.root22.402.3072.88 ± 6.8424*Terminalia chebula* Retz.fruit10.4028.295.14 ± 0.5225*Terminalia chebula* Retz.gall0.308.832.35 ± 0.18^a^(W/W) = gram unit

Preparation of STF and its component extracts {#Sec4}
---------------------------------------------

The dried powder of STF and its ingredients were extracted 3 times by ethanol 80% at ratio of 1:10 (w/v) using ultrasonic sonicator machine (BANDELIN, Germany) controlled the ultrasonic frequency at 30 kHz and the temperature between 25 and 35 °C for 30 min and then filtrated through filter paper no. 4 (Whatman, England). The extraction solution was concentrated by rotary evaporator under 50 °C and at a pressure between 150 and 180 mbar (Buchi, Switzerland) and each sample was stored at −80 °C prior to lyophilization. The calculated % yield (w/w) was shown in Table [1](#Tab1){ref-type="table"}. The lyophilized powder (10 mg) was reconstituted with 80% ethanol, vortexed and centrifuged at 22136.4 g for 10 min at 4 °C. The extraction solution was then filtered through 0.22 μm polyvinylidene difluoride membrane (PVDF) (Vertical Chromatography, Thailand) to remove the extraction residues.

Identification of active compounds by HPLC analysis {#Sec5}
---------------------------------------------------

HPLC analysis was applied for identification and quantification of the STF extracts and its possible active compounds. Briefly, phenolic compounds (including gallic acid (GA), p-coumaric acid, kojic acid, caffeic acid, ferulic acid, and vanillic acid) and piperine (PP) were selected as reference markers from literature-based review of STF components. Chromatographic profiles of STF extract and reference compounds were detected by the Waters 2998 Photodiode Array (PDA) and the analytical procedure was performed using Alliance e2695 (Water, USA) and Waters Empower 2 software. Phenumenix C18 5 μm (4.6 mm × 250 mm) and Sunfire C18 5 μm (4.6 mm × 150 mm) (Water, Ireland) were used as a stationary phase for analysis of phenolic compounds and piperine, respectively. The mobile phases at a flow rate 1 mL/min composed of 1% acetic acid in Milli-Q water or 10 mM ammonium acetate (pH 6.8) (solvent A) for phenolics and PP, respectively, and 100% methanol (solvent B) for both phenolics and PP. For analysis of phenolic substances, a gradient condition was used as follows: 0 min, 98% A/2% B; 3 min, 90% A/10% B; 5 min, 80% A/20% B; 7 min, 70% A/30% B; 13 min, 85% A/15% B; 14 min, 100% B; 16--18 min, 98% A/2% B. The peaks were detected at wavelengths 210--400 nm. For analysis of PP, an isocratic elution with 25% A/75% B was used and chromatograms were detected at 340 nm. The identification of phenolic compounds and PP in STF extracts was presented in Fig. [1a](#Fig1){ref-type="fig"} and [b](#Fig1){ref-type="fig"}. The GA and PP contents in STF were 0.175 (W/W) % and 0.602 (W/W) %, respectively.Fig. 1The HPLC fingerprints of phenolic compounds (**a**) and piperine (PP) (**b**) in STF extracts. Peak details; 1: kojic acid (RT: 6.103 min); 2: gallic acid (GA) (RT: 6.940 min); 3: caffeic acid (RT: 10.211 min); 4: vanellic acid (RT: 10.433 min); 5: p-coumaric acid (RT: 11.524 min); 6: ferulic acid (RT: 12.039 min)

Screening of free radical scavenging activity {#Sec6}
---------------------------------------------

2, 2-dipheny-1-picrylhydrazyl (DPPH), a stable free radical molecule, was commonly used to determine free radical scavenging activity as previously described \[[@CR10]\]. STF, its component extracts and reference compounds (GA, PP and L-ascorbic acid) were prepared by diluting serially with 80% ethanol (3.75, 15, 30, 60, 120 μg/mL). The absorbance was detected spectrophotometrically at 520 nm at 0 and 15 min by a microplate reader SpectraMAX M5 (Molecular Devices, CA).

Cell culture and treatments {#Sec7}
---------------------------

NHDFs divided from adult female skin were cultured in 2% FBM supplemented with 1% penicillin (100 units/mL) and streptomycin (100 μg/mL) under 37 °C, 5% CO~2~ in incubator. Upon reaching 80--100% confluency in T75 flask, cells were treated with indomethacin, STF extracts and its reference markers (GA and PP). Stock solutions of all test compounds were freshly prepared with 80% ethanol and filtrated through 0.22 μm PVDF filter. To induce inflammation and oxidative stress of NHDFs, IL-1β was used in this study and diluted with serum-free medium and indomethacin applied for a positive control was dissolved in 1.80% dimethyl sulfoxide (DMSO) solution.

Cell viability assay {#Sec8}
--------------------

MTT assay was performed to determine non-toxic concentrations of vehicles (80% ETOH and DMSO) and test compounds for further cellular studies. Briefly, cells were pre-incubated with vehicle or test compounds at vary concentrations for 24 h and 200 μL of MTT reagent (0.2 mg/mL) was then added into each well and incubated for 4 h. To dissolve formazan product, 200 μL of DMSO reagent were added into each well followed by measuring the absorbance at 595 nm using a spectrophotometer (SpectraMAX M5, Molecular Devices, CA).

Determination of intracellular ROS formation {#Sec9}
--------------------------------------------

Intracellular ROS formation in NHDFs was determined by flow cytometry using 2′, 7′-dichlorofluorescein diacetate (DCFH-DA), a stable and non-fluorescent dye. To investigate ROS production induced by IL-1β, NHDFs were treated with IL-1β (0.1, 0.5, 1, 10 ng/mL) for 30 min. To assess inhibitory effects of STF extracts and its active compounds on ROS generation. NHDFs were pre-treated with GA (0.3, 1, 3 μg/mL), PP (1, 3, 10, 30 μg/mL), STF extracts (3, 10, 30 μg/mL) and vehicle reagent (ETOH 80%) following treated concentrations for 30 min prior to treatment with IL-1β (1 ng/mL) for 30 min and then incubated with 5 μM DCFH-DA for 30 min. The oxidized DCFDA indicating ROS formation was measured using flow cytometry (BD Biosciences, USA) and fluorescence intensity was analyzed by FlowJo vX.0.7 software (TreeStar Inc, Ashland, OR, USA).

Gene expression profiling study {#Sec10}
-------------------------------

To assess the effect of STF and its active compounds on human-whole genome expression. NHDFs were treated with indomethacin (50 μM), GA (0.3, 1, 3 μg/mL), PP (1, 30 μg/mL) and STF extracts (3, 10, 30 μg/mL) for 30 min prior to treatment with IL-1β (1 ng/mL) for 4 h. Briefly, total mRNA of each treatment was isolated by Illutra RNA spin Mini RNA isolation Kit (GE Healthcare, UK). The concentration and purity of isolated mRNA were determined using NanoVue UV/visible spectrophotometer (GE Healthcare, UK) and Qubit® quantitation assay kit (Life Technologies, USA) followed by the instructions. To estimate RNA integrity, RNA samples were analyzed using Agilent RNA 6000 Nano kit (Agilent Technologies, USA) with Agilent 2100 Bioanalyzer (Agilent Technologies, USA). The 28S/18S ratio of total RNA was equal and greater than 2.0 and the RNA Integrity Number (RIN) was greater than 7.0. Then, the total mRNA was converted into complementary RNA (cRNA), amplification and biotin labelling were carried out according to the Illumina TotalPrep™ RNA Amplification kit (Life Technologies, USA). Biotin-labelled cRNA (750 ng) was hybridized with Human HT-12 V4 BeadChip (Illumina, USA) following the whole genome expression direct hybridization assay protocol (Illumina, USA). Briefly, 15 μL of each cRNA sample was pipetted onto the HumanHT-12 v4 BeadChip (Illumina, USA) and chamber was then incubated in hybridization oven at 58 °C for 14--20 h. The BeadChip was washed out and then stained with Cy3-STFeptavidin (GE Healthcare, UK), which was further scanned with HiScan array scanner (Illumina, USA). The backgrounds of intensity were subtracted and operated under GenomeStudio™ gene expression module 1.0 software. All data were exported as Binary Manifest Files (\*.bgx), then converted to a Comma-Separated Values (CSV) file imported into Microsoft Excel program for Window.

Microarray data analysis {#Sec11}
------------------------

The signal intensities of samples were normalized and analyzed using Microsoft Excel program version 2013. Data analysis was performed as described in Additional file [1](#MOESM1){ref-type="media"}: Figure S1. Twelve human housekeeping genes (Additional file 1: Table S1) were applied for normalization of each gene intensity using the normalization factor to adjust the unequal distribution of signal intensity. The normalized and non- normalized microarray data had deposited in the Gene Expression Omnibus (GEO) databases with accession number GSE86798 (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE86798>). The normalized values were used to calculate fold change, which was converted into logarithmic base 2. To determine the up-regulated or down-regulated genes, the Student's *t*-test was performed to estimate significant difference of gene expression based on *P* \< 0.05 with fold change that cut off ≥ 2 or ≤ 0.5 times compared with untreated control group or IL-1β-treated group without compound treatment. To investigate the effects of STF extract and its active compounds on gene expression analyzed by Gene Ontology (GO) classification and pathway enrichment analysis using PANTHER web-database followed a protocol \[[@CR11]\].

Quantitative real-time polymerase chain reaction (qRT-PCR) {#Sec12}
----------------------------------------------------------

qRT-PCR was used to validate differential gene expression from IL-1β stimulation. Total RNA of all samples were isolated by Illutra RNA spin Mini RNA isolation Kit (GE Healthcare, UK) and converted into complementary DNA (cDNA) using ImProm-II ™ reverse transcription system (Promega, USA). The primers were designed and verified by Primer-Blast from NCBI website (<https://www.ncbi.nlm.nih.gov/tools/primer-blast/>). The PCR reaction was performed using ABI Prism 7300 Real Time PCR System (Applied Biosystems, USA) and KAPA SYBR Fast qPCR kits (Kapa Biosystems, UK). The fast amplification condition: enzyme activation step at 95 °C for 3 min, annealing step at 60 °C for 30 s, and an extension step at 72 °C for 3 s for a total of 40 cycles. The list of primer sequences were described in (Additional file [2](#MOESM2){ref-type="media"}: Table S1). The relative normalized genes expression were estimated using ΔΔCt method and each gene expression result was normalized with GADPH being housekeeping gene and internal control in the experiment. The experiment was carried out in triplicate. The results of qRT-PCR analysis were shown in Additional file 2: Figures S1 and S2.

Statistical analysis {#Sec13}
--------------------

Data were expressed as means and standard deviation (SD) or standard error of the mean (SEM). The significantly statistical values concerned at *P* \<0.05 were estimated by Unpaired t- test and one-way analysis of variance (ANOVA) followed by Dunnett's post hoc test using GraphPad Prism version 5 for Windows (GraphPad Software Inc., San Diego, CA, USA).

Results {#Sec14}
=======

The antioxidant activities of STF and its ingredients {#Sec15}
-----------------------------------------------------

The free radical scavenging activities of STF extracts, its components and possible active compounds including GA and PP were examined by DPPH assay. As shown in Table [1](#Tab1){ref-type="table"}, STF extracts, GA and L-ascorbic acid had abilities to scavenge DPPH radical in a dose-dependent manner, whereas PP had no free radical scavenging properties. Based on IC~30~ value, STF's components which ranked in the top five for free radical scavenging activities were *Terminalia chebula* Retz. (gall), *Terminalia chebula* Retz. (fruit), *Myristica fragrans* Houtt. (fruit), *Merremia vitifolia* (Burm.f.) Hallier.f. and *Myristica fragrans* Houtt. (mace), respectively. In addition, the extracts from analytical camphor and gum of *Ferula assa-foetida* Regel showed no free radical scavenging properties.

Cytotoxicity assessments: inflammatory inducer, solubilizing vehicles, STF and its active compounds {#Sec16}
---------------------------------------------------------------------------------------------------

The results showed that treatment of NHDFs with vehicles and test compounds including STF extracts, GA and PP (3.75 to 30 μg/mL), indomethacin (1--100 μM) and IL-1β (0.1,1,10 ng/mL) for 24 h did not affect NHDFs viability compared to untreated control cells (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Cytotoxicity of STF extracts (**a**), Piperine (PP) (**b**), Gallic acid (GA) (**c**), Indomethacin (**d**), IL-1β (**e**), ETOH80% (**f**) and DMSO (**g**) on NHDFs viability. The results were obtained from at least triplicate experiments, One-Way ANOVA (Dunnett's post hoc test) was used to determine statistical significance and the data are represented as Mean ± SD. \**P* \<0.05; \*\**P* \<0.01; \*\*\**P* \<0.001 compared with control group

The inhibitory effects of STF extracts and its active substances on intracellular ROS formation induced by IL-1β in NHDFs {#Sec17}
-------------------------------------------------------------------------------------------------------------------------

As shown in Fig. [3a](#Fig3){ref-type="fig"}, IL-1β (1 ng/mL and 10 ng/mL) significantly enhanced ROS generation in NHDFs (*P* \<0.01 and \<0.001) determined by flow cytometry. The results of oxidized-DCFDA fluorescence indicated that STF extracts (10 and 30 μg/mL) and the highest dose of GA (3 μg/mL) and PP (30 μg/mL) significantly suppressed ROS production in NHDFs compared with IL-1β-induced cells (Fig. [3b-d](#Fig3){ref-type="fig"}). Additionally, treatment with vehicle control (Fig. [3e](#Fig3){ref-type="fig"}), STF extracts or its active compounds alone did not affect ROS formation in NHDFs.Fig. 3The effects of STF extracts and its active compounds on ROS formation was assessed by DCFDA-flow cytometry. IL-1β significantly enhanced ROS formation in a dose-dependent manner in IL-1β-treated NHDFs (**a**). The pretreatment of STF extracts (**b**), GA (**c**) and PP (**d**) can attenuate IL-1β-induced intracellular ROS levels whereas, treatment with each compound alone (**b**-**d**) and vehicle reagents (ETOH 80%) (**e**) didn't affect ROS generation. DCFDA intensity data were presented as Mean ± SD at least three experiments. The statistical significant between control and IL-1β-treated cells was evaluated by Unpaired *t*-test and between IL-1β-treated and test compound--treated cells was assessed by one-way ANOVA followed by Dunnett's post hoc test. \*\**P* \< 0.01, \*\*\* *P* \< 0.001 compared with control. ^\#^ *P* \< 0.05, ^\#\#^ *P* \< 0.01 and ^\#\#\#^ *P* \< 0.001 compared with IL-1β-treated cells

IL-1β modulated gene expression profile in fibroblasts: the effects of STF and its active compounds {#Sec18}
---------------------------------------------------------------------------------------------------

To investigate the role of IL-1β on transcriptional profiling of fibroblasts, the volcano plot of whole human gene expressions (47,231 probes) demonstrated the differential expression of IL-1β-treated cells compared with untreated cells. Following the analytical criteria, the volcano plot was shown total of 84 genes with significantly up-regulated expression (54 genes) and down-regulated expression (30 genes) detected in IL-1β-treated cells compared to untreated control cells (Fig. [4a](#Fig4){ref-type="fig"} and Additional file [3](#MOESM3){ref-type="media"}: Table S1 and S2). The gene GO analysis of up- and down- regulated genes was shown in Fig. [4b](#Fig4){ref-type="fig"}. The up-regulated genes in IL-1β-treated cells mainly involved signaling pathways such as inflammation, apoptosis, heterotrimeric G-protein activation, and adaptive immune activation. However, only two pathways from PANTHER pathway enrichment analysis comprising BICR3, CXCL1, CXCL2, NFKBIA, IL-8 and IL-6 were significantly moderated by IL-1β (Table [3](#Tab3){ref-type="table"}). 22 genes of the 54 up-regulated genes were targeted genes associated with NF-кB transcription, including related transcription factors, chemokines, cytokines and immunoreceptors regulated by NF-кB (Table [2](#Tab2){ref-type="table"}).Fig. 4The differential expression of genes in NHDFs treated with IL-1β when compared with non-treated cells. The significantly altered genes (30 down-regulated and 54 up-regulated) induced by IL-1β were indicated by yellow dots and red dots, respectively (**a**). The Gene Ontology (GO) classification of 84 altered genes was performed using PANTHER classification system analysis (**b**). Table 2The summery of 22 target genes involved in transactivation of NF-кB induced by IL-1β in NHDFs. All gene description and functional annotation were referred from PANTHER and NCBI databasesGroupGene symbolDescription/FunctionTranscription factor and their modulatorsCEBPDCCAAT/Enhancer Binding Protein (C/EBP), Delta /regulation of genes involved in immune and inflammatory responses (macrophage)IRF1Interferon Regulatory Factor 1/ an activator of interferons alpha and beta transcription, regulations of apoptosis and tumor-suppressionNFKB1Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 1/ sequence-specific DNA binding transcription factor activity and transcription factor bindingNFKBIA (IκBα)Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells Inhibitor, Alpha / inhibits the activity of dimeric NF-kappa-B/REL complexesNFKBIZ (IκBZ)Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells Inhibitor, Zeta / a member of the ankyrin-repeat family, produce IL6 secretion induced by lipopolysaccharide.TNFAIP3Tumor Necrosis Factor, Alpha-Induced Protein3/ ubiquitin-protein transferase activity and inhibit NF-kappa B activation as well as TNF-mediated apoptosisChemokines and InterleukinsCCL2Chemokine (C-C Motif) Ligand 2/ A member of the CC subfamily contains chemotactic activity for monocytes and basophilsCXCL1Chemokine (C-X-C Motif) Ligand 1 (Melanoma Growth Stimulating Activity, Alpha)/ chemotactic activity for neutrophilCXCL2Chemokine (C-X-C Motif) Ligand 2/ produced by activated monocytes and neutrophils and expressed at sites of inflammationCXCL6Chemokine (C-X-C Motif) Ligand 6 /chemotactic activity for neutrophilIL-6Interleukin 6/ cytokine activity and interleukin-6 receptor, relation with B-cells, lymphocyte and monocyte differentiation,inflammationIL-8Chemokine (C-X-C Motif) Ligand 8/ the major mediators of the inflammatory response, chemotactic activity that attracts neutrophils, basophils and T-cellImmunoreceptorsCD83CD83 Molecule/ an antigen presentation or the cellular interactions that follow lymphocyte activationNOD2Nucleotide-Binding Oligomerization Domain Containing 2/ protein kinase binding and peptidoglycan binding.CFBComplement Factor B / serine-type endopeptidase activity and complement bindingCell adhesion molecules and receptorsICAM1Intercellular Adhesion Molecule 1/ a cell surface glycoproteinNINJ1Ninjurin 1/ Homophilic cell adhesion moleculeVCAM1Vascular Cell Adhesion Molecule 1/ integrin binding and primary amine oxidase activityStress response genesSOD2Superoxide Dismutase 2, Mitochondrial/ deSTFoys superoxide anionsEnzymesPTGESProstaglandin E Synthase / catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2)Early response genesTNFAIP2Tumor Necrosis Factor, Alpha-Induced Protein 2/ a mediator of inflammation and angiogenesisMiscellaneousTFPI2Tissue Factor Pathway Inhibitor 2/ serine-type endopeptidase inhibitor activity and extracellular matrix STFuctural constituent

The 84 genes which were significantly altered (*P* \< 0.05, fold change ≥2 or ≤ 0.5) were considered to be the target genes. To determine the effects of test compounds on IL-1β-treated cells, the expression profiling of 84 genes modulated by STF extracts, GA, PP and indomethacin were observed compared to IL-1β -treated cells, as shown in Fig. [5](#Fig5){ref-type="fig"}. In upregulated genes induced by IL-1β, treatment with STF (3 μg/mL) provided greater effects on downregulation of inflammatory and immune genes involved in NF-κB components (NFKB1,NFKBIA,NFKBIZ), chemokines (CCL2,CXCL1,CXCL2,IL8), transcriptional regulator (IRF1), prostaglandin E synthase (PTGES) and TNF alpha induced protein family (TNFAIP2, TNFAIP3, TNFAIP6) than indomethacin in IL-1β-treated cells. Furthermore, STF noticeably induced several gene expressions associated with breast cancer anti-estrogen resistance 3 (BCAR3), cluster of differentiation 83 (CD83), nucleotide-binding oligomerization domain containing 2 (NOD2). Meanwhile, gallic acid (3 μg/mL) appeared to give the greatest inhibition of IL-1β-induced MSC and ZC3H12A genes (Fig. [5a](#Fig5){ref-type="fig"}). Additionally, STF reversed the effects of IL-1β-mediated downregulation of some genes such as early B-cell factor 3 (EBF3), LIM domain binding 2 (LDB2) and PHD finger protein 13 (PHF13). Moreover, STF enhanced the effects of IL-1β-mediated downregulation of SLC38A2 and STC genes (Fig. [5b](#Fig5){ref-type="fig"}). The overall of gene expression profile modulated by IL-1β, indomethacin, STF and its active compounds were demonstrated in Additional file [4](#MOESM4){ref-type="media"}: Table S1.Fig. 5The heat map of target genes of 54 up-regulated genes (**a**) and 30 down-regulated genes (**b**) showed differential pattern of gene expressions in NHDFs pretreated with test compounds prior to IL-1β (1 ng/mL) challenge. Column details: A: indomethacin (50 μM) + IL-1β; B: GA 3 μg/mL+ IL-1β; C: PP 30 μg/mL+ IL-1β and D: STF 3 μg/mL+ IL-1β

Furthermore, Fig. [6](#Fig6){ref-type="fig"} demonstrated the effect of all test compounds on gene expression pattern following the findings showing 1,653 significantly altered genes in IL-1β-treated cells compared to untreated control cells (Fig. [4a](#Fig4){ref-type="fig"}). Treatment with indomethacin (Fig. [6a](#Fig6){ref-type="fig"}), PP (Fig. [6b](#Fig6){ref-type="fig"} and [c](#Fig6){ref-type="fig"}), GA (Fig. [6d](#Fig6){ref-type="fig"}-[f](#Fig6){ref-type="fig"}) and STF differently modulated gene expression patterns (Fig. [6g](#Fig6){ref-type="fig"} -[i](#Fig6){ref-type="fig"}).Fig. 6The difference of target gene expression patterns of test compounds in NHDFs induced by IL-1β 1 ng/mL for 4 h (**a-i**); (**a**) Indomethacin 50 μM,(**b**) PP 1 μg/mL,(**c**) PP 30 μg/mL, (**d**) GA 0.3 μg/mL, (**e**) GA 1 μg/mL and (**f**) GA 3 μg/mL, (**g**) STF 3 μg/mL, (**h**) STF 10 μg/mL, **(i**) STF 30 μg/mL

Discussion {#Sec19}
==========

In this study, we first investigated biologically active compounds of STF using LC separation and its pharmacological effects related to the anti-inflammatory and antioxidant actions using primary human fibroblast culture model and microarray analysis. The HPLC analysis revealed that PP and phenolic compounds including GA were present in STF. In a previous study using reverse-phase HPLC \[[@CR12]\], PP was also present in long pepper (*Piper retrofractum* Vahl.) and black pepper (*Piper nigrum* L.). In addition, other previously reported study cited GA and PP as having anti-inflammatory and antioxidant activities and thus both compounds were chosen as reference markers for investigating the effects of STF extracts in our study \[[@CR13]--[@CR15]\].

Since ROS play a role in initiation and progression of inflammatory disorders. Our results indicated that STF and its components were able to scavenge DPPH free radicals, although their abilities to scavenge DPPH were less than ascorbic acid base on IC~30~ values. Among all STF's components, *Terminalia chebula Retz.* (gall and fruit), showed the strongest free radical scavenging activities. Previous studies also reported that tannins and phenolic compounds, including GA, punicalagin, chebulagic acid, casuarinin and chebulanin found in *Terminalia chebula* Retz. were accountable for its antioxidant potentials \[[@CR16]\]. Concurrently, PP standard failed to yield free radical scavenging activities while black pepper and long pepper, which were the major constituents in STF extracts, had minimal ability to scavenge the DPPH radicals. It is possible that free radical scavenging actions of black pepper and long pepper may be attributed to other phytochemical substances \[[@CR17]\]. Thus, the DPPH results suggested that GA and other unidentified compounds present in the STF's components may be responsible for the free radical scavenging activity of the formula.

Inflammatory and oxidative stress events are associated with the production of pro-inflammatory cytokines through NADPH oxidase complex \[[@CR18]\] which subsequently produce ROS such as superoxide and hydrogen peroxide in human fibroblasts. The flow cytometry analysis supported that pro-inflammatory cytokine IL-1β in NHDFs can induce ROS formation. Furthermore, this study also explored antioxidant effects of STF extracts, GA and PP on IL-1β-treated NHDFs. Our study demonstrated that pretreatment of the cells with STF and its active compounds can suppress IL-1β-induced intracellular ROS levels. Previous reports also demonstrated that GA and PP showed abilities to promote mRNA levels and activities of antioxidant enzymes and inhibition of lipid peroxidation \[[@CR14], [@CR19]\]. Additionally, the concentrations at which STF demonstrated its inhibitory effects on ROS formation were much higher than those of GA. Other unidentified substances in the formula may also contribute to antioxidant actions of the STF extracts.

IL-1β plays critical roles in regulating inflammatory and antioxidant genes related to cytokines, chemokines, adhesion molecules, immunomodulators, apoptotic regulators, and growth factors involved in physiological, pathological and oxidative stress events. In our study, total 84 genes were significantly altered; 54 genes were up-regulated and 30 genes were down regulated in IL-1β-treated NHDFs and, in consistent with previous studies, similar pattern of altered genes or gene expression profiling was observed fibroblast model of inflammation \[[@CR20], [@CR21]\]. In addition, it is well known that IL-1 can activate NF-кB in various cell types through canonical NF-кB-activating cascades \[[@CR22], [@CR23]\]. Our results indicated that the member of NF-кB transcription components, NFKB1, NFKBIA (IκBα) and NFKBIZ genes, were significantly upregulated in IL-1β-treated NDHFs. Additionally, treatment with IL-1β upregulated the mRNA of SOD2, which serves as the primary antioxidant defense in mitochondria that changes superoxide molecules into hydrogen peroxide and oxygen and could be regulated by NF-кB \[[@CR24], [@CR25]\]. The microarray results suggesting altered expression of genes involved in mitochondrial dysfunction were in consistent with the flow cytometric findings showing that the presence of IL-1β enhanced ROS production in NHDFs as augmented ROS generation can be associated with mitochondrial injury \[[@CR26]\]. Thus, it is possible that upregulation of antioxidant defenses may reflect an adaptive mechanisms in response to inflammatory challenge.

Currently, it has been suggested that more than 150 target genes including transcription factors, cytokines, chemokines and immune mediators can be regulated by NF-кB \[[@CR27]\]. The crosstalk of inflammatory and immunomodulatory pathways with multiple other pathways unrelated to NF-кB signaling is therefore possible \[[@CR28]\]. Interestingly, it is well recognized that NOD2 is involved in host defense against bacterial infections and various inflammatory diseases. Previous studies showed that pro-inflammatory cytokines such as IFN-γ, TNF-α are able to upregulate NOD mRNA and protein levels \[[@CR29]\]. Furthermore, NOD2 signaling pathway also participates in NF-кB activation \[[@CR30]\] resulting in active IL-1β secretion \[[@CR31]\]. Additionally, BIRC3 encodes a member of the inhibitor of apoptosis protein (IAP) family, which plays the potential role in caspase-1 modulation in association with inflammasome activation, which could be mediated by IL-1β \[[@CR32]\]. Furthermore, IAP encoded by BIRC3 gene is suggested to serve as a regulator of NF-кB signaling \[[@CR33]\]. Our study showing upregulation of NOD2 and BIRC3 gene by IL-1β in human fibroblasts supports the role of IL-1β in acute inflammation; moreover, it also contributes to immune activation in fibroblasts through secreting multiple biochemical mediators such as cytokines, chemokines, transcription factors, proteases, and apoptosis regulators involved in the downstream of NF-кB activation.

Interestingly, PANTHER pathway analysis indicated that IL-1β could upregulate interleukin and CCKR signaling in NHDFs (Table [3](#Tab3){ref-type="table"}). Previous evidence showed that IL-1β had the potential to upregulate important genes including NFKBIA and IL-8 involved in activation of NF-кB cascade associated with CCKR signaling \[[@CR34], [@CR35]\], as well as IL-6 and IL-8, the critical pro-inflammatory mediators, involved in interleukin signaling. Our findings also indicated the effects of IL-1β on CCKR and prostaglandins (Additional file [3](#MOESM3){ref-type="media"}: Table [1](#Tab1){ref-type="table"}) postulated to be involved in pain sensitization \[[@CR36]\]. In addition, increased expression of IL-6 and IL-8 genes by IL-1β in our study support the inflammatory role of IL-1β as previous in vitro study observing enhanced IL-6 and IL-8 levels in rheumatoid arthritis synovial fibroblasts \[[@CR37]\].Table 3List of significantly up-regulated genes in IL-1β-treated NHDFs using PANTHER pathway enrichment analysis. *P* \< 0.05 was considered statistically significantNo.Pathway (PANTHER pathway ID)Gene SymbolProtein class*p*-value1CCKR signaling mapBIRC3protease inhibitor2.17E-02CXCL1chemokineCXCL2chemokineNFKBIAphospholipaseIL-8chemokine2Interleukin signaling pathwayIL-6interleukin superfamily3.78E-02IL-8chemokine

We also investigated the effects of indomethacin used as the positive control, STF extracts and its active compounds (GA and PP) on 84 target genes induced by IL-1β (Fig. [5a and b](#Fig5){ref-type="fig"}). All test compounds can downregulate the expression of genes involved in NF-кB signaling pathway through three NF-кB modulated pathways \[[@CR38]\]. NFKB1 and NFKB1A genes which were significantly down-regulated more than 2-fold by STF (Fig. [5a](#Fig5){ref-type="fig"}) participate in the pathways that can counteract the NF-кB upstream signaling including the inhibition of phosphorylation of IKK complexes and IKB degradation, the inhibition of mobilization of NF-кB into cell nucleus and binding with specific DNA sequence.

In addition, our study showed that STF extracts led to a significant down-regulation (\>1.5-fold) of IL-1β-induced IRF1 gene involved in COX-2 expression \[[@CR39]\]. Moreover, the STF extracts also attenuated many inflammatory chemokine and interleukin genes (Fig. [5a](#Fig5){ref-type="fig"}) such as CXCL1, CXCL2, CCL2 IL-6 and IL-8 enhanced by IL-1β which were previously suggested to associate with clinical analgesia \[[@CR40]\] and inflammatory hypernociception \[[@CR41]\]. On the contrary, all test compounds except STF significantly downregulated (\>2-fold) IL-1β-induced expression of CD83, and NOD2 genes. CD83 is associated with the activation of NF-кB binding and increased level of PGE~2~ \[[@CR42]\]. Nevertheless, the mechanism by which STF enhances the overexpression of NOD2 gene involved in innate immune and inflammatory responses \[[@CR43]\] needs further investigation. Furthermore, STF reversed the effects of IL-1β on downregulation of various genes (Fig. [5b](#Fig5){ref-type="fig"}), such as, EBF3 associated with B lymphocyte differentiation \[[@CR44]\], bone and neuronal genesis \[[@CR45]\] and tumor suppression \[[@CR46]\]. Moreover, STF remarkably downregulated expression of STC2 gene involved in endoplasmic reticulum-stress through PERK pathway in nonalcoholic fatty liver disease \[[@CR47]\].

Our results revealed for the first time that STF and its active compounds including PP and GA can modulate various genes involved in intracellular signaling cascades including inflammatory and immunomodulatory signaling pathways. However, our work provided only the evidence-based data on gene expression profiles affected by STF using primary fibroblast model of inflammation. Thus, further studies are warranted to elucidate their therapeutic targets integrating diverse signaling pathways and other pharmacological fields such as pharmacokinetics, pharmacodynamics and herb-drug interactions relating with therapeutic efficacy for development of STF as a novel anti-inflammatory agent.

Conclusions {#Sec20}
===========

In summary, HPLC analysis has revealed the presence of GA as the major phenolic in STF extracts and the presence of PP as the major compound in pepper, the main component herb in STF, indicating that both GA and PP could be possible active ingredients in STF extracts. Pathway enrichment analysis of microarray data indicated that IL-1β can enhance various genes involved in interleukin and CCRK signaling pathways in NHDFs. In targeted gene analysis, all test compounds (indomethacin, STF, GA and PP) provided diverse gene expression profiling involving multiple transcriptional factors including NF-кB as well as inflammatory signaling in IL-1β-pretreated NHDFs.
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